SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

By Jonathan Stempel (Reuters) -Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene ...

The price of Rebif has increased four times faster than the rate of inflation, with Kay's insurer deciding to stop covering ...

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

As an FDA advisory panel meets Wednesday to vote on whether to recommend approval of Sanofi’s MS drug Lemtrada, patient opinion leaders have already voiced their view. A small majority told ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly from 2012 to 2021, with the largest hikes in multiple sclerosis (MS) drugs, ...

ST. PAUL - The Minnesota Wild placed goaltender Josh Harding, who has multiple sclerosis, on injured reserve Wednesday because he needs to make changes to his medications. Harding, who leads the NHL ...